life sciences – Globalstocksnews

Lexaria Bioscience (LEXX.NASDAQ) (LEXX.CSE) $11 million financing supports R&D program targeting high blood pressure and SARS-CoV-2 infection

February 16, 2021March 22, 2021globalstocksnews

VANCOUVER, BC – Lexaria Bioscience’s (LEXX.NASDAQ) (LEXX.CSE) drug delivery technology, DehydraTECHTM improves the “bioavailability” of pharmaceutical ingredients. “Bioavailability is the rate and extent [...]

Medexus (MDP.V) expands specialty pharmaceuticals portfolio

February 1, 2021February 16, 2021globalstocksnews

VANCOUVER, BC – Medexus Pharmaceuticals (MDP.V) is a specialty pharmaceuticals company that delivers innovative medicines to under-served segments of the market. With over [...]

Warren Buffett (BRK-B) bails on Costco (COST.Q), and buys into Pfizer (PFE.NYSE)

November 23, 2020December 14, 2020globalstocksnews

On November 17, 2020 public filings revealed that Warren Buffett’s Berkshire Hathaway (BRK-B) dumped all its shares in Costco (COST.Q), while loading up [...]

XPhyto (XPHY.C) advances a COVID-screener that works like a pregnancy test

July 19, 2020July 21, 2020globalstocksnews

On July 6, 2020 XPhyto Therapeutics (XPHY.C) announced that its exclusive diagnostic partner, 3a-Diagnostics took a major step towards the development of an [...]